Hao Wang

BGI Group (China) (CN)

Research Areas

Discover Papers by Hao Wang

Access 250+ million papers and cite this researcher's work with AI assistance

Try AnswerThis Free →

H-index

Publications

1850

Citations

10760

i10-index

223

Publications & Citations Over Time

Top Cited Publications

Want to find and read papers by this researcher? AnswerThis gives you instant access.

Title	Year	Citations
Endovascular Thrombectomy with or without Intraven...	2020	824
Complete Response to Neoadjuvant Chemoradiotherapy...	2005	517
CD73 promotes hepatocellular carcinoma progression...	2019	251
Atrial natriuretic peptide in cardiovascular biolo...	2015	201
Morbidity and Mortality of Patients Who Underwent ...	2021	184
Phase II and Pharmacodynamic Study of the Farnesyl...	2003	171
A narrative review of tumor heterogeneity and chal...	2021	146
PCSK6-mediated corin activation is essential for n...	2015	143
COVID-19 with cystic features on computed tomograp...	2020	130
Resibufogenin suppresses colorectal cancer growth ...	2018	125

Publications

1.
Endovascular Thrombectomy with or without Intravenous Alteplase in Acute Stroke
Year: 2020Citations: 824DOI: 10.1056/nejmoa2001123
2.
Complete Response to Neoadjuvant Chemoradiotherapy in Esophageal Carcinoma Is Associated With Significantly Improved Survival
Year: 2005Citations: 517DOI: 10.1200/jco.2005.05.017
3.
CD73 promotes hepatocellular carcinoma progression and metastasis via activating PI3K/AKT signaling by inducing Rap1-mediated membrane localization of P110β and predicts poor prognosis
Year: 2019Citations: 251DOI: 10.1186/s13045-019-0724-7
4.
Atrial natriuretic peptide in cardiovascular biology and disease (NPPA)
Year: 2015Citations: 201DOI: 10.1016/j.gene.2015.06.029
5.
Morbidity and Mortality of Patients Who Underwent Minimally Invasive Esophagectomy After Neoadjuvant Chemoradiotherapy vs Neoadjuvant Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma
Year: 2021Citations: 184DOI: 10.1001/jamasurg.2021.0133
6.
Phase II and Pharmacodynamic Study of the Farnesyltransferase Inhibitor R115777 as Initial Therapy in Patients With Metastatic Pancreatic Adenocarcinoma
Year: 2003Citations: 171DOI: 10.1200/jco.2003.08.040
7.
A narrative review of tumor heterogeneity and challenges to tumor drug therapy
Year: 2021Citations: 146DOI: 10.21037/atm-21-1948
8.
PCSK6-mediated corin activation is essential for normal blood pressure
Year: 2015Citations: 143DOI: 10.1038/nm.3920
9.
COVID-19 with cystic features on computed tomography
Year: 2020Citations: 130DOI: 10.1097/md.0000000000020175
10.
Resibufogenin suppresses colorectal cancer growth and metastasis through RIP3-mediated necroptosis
Year: 2018Citations: 125DOI: 10.1186/s12967-018-1580-x

About Hao Wang

Hao Wang is a researcher with 1850 publications and 10760 citations. They are affiliated with BGI Group (China). Their research focuses on . With an h-index of 52, they are among the top researchers in their field.

Citation Distribution

Distribution of citations across publications

Research Smarter

AnswerThis uses AI to help you search, understand, and cite research from Hao Wang and 250M+ other papers.

AI-powered research assistance
Automatic citations and references
Advanced academic writing tools

Research Area Breakdown

Publication Types

Publication type data not available

Impact Metrics Over Time

Citations per publication by year